PROTEASE INHIBITOR (PI)
Crixivan is a prescription drug approved by the Food and Drug Administration (FDA) to treat HIV infection in combination with other antiretroviral medications. Crixivan is also referred to by its drug name, Indinavir, and by the abbreviation IDV.
Crixivan is an antiviral medication of the protease inhibitor (PI) class. Crixivan is believed to work by preventing HIV from replicating in cells.
How do I take it?
Prescribing information states that Crixivan is taken every eight hours.
Crixivan comes in capsule form.
The FDA-approved label for Crixivan lists common side effects including headache, mood changes, nausea, loss of appetite, vomiting, heartburn, sensations of numbness or tingling, and changes in the shape or location of body fat.
Rare but serious side effects listed for Crixivan include severe skin reactions.
For more details about this treatment, visit:
Crixivan – RxList
Overview of HIV Treatments – AIDS.gov